Procurement Summary
Country: Ukraine
Summary: Chlorhexidine, Solution for External Use 0.05% Per 100 Ml; Epinephrine 1.82 Mg/Ml, Solution for Injection, Ampoule; Ammonia, Solution for External Use, 10%, 100 Ml Each; Chloropyramine, Solution...
Deadline: 20 May 2026
Posting Date: 16 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141421888
Document Ref. No.: UA-2026-05-15-010302-a
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 140000
CPV Classification
33600000 - Pharmaceutical products
33690000 - Various medicinal products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33660000 - Medicinal products for the nervous system and sensory organs
33670000 - Medicinal products for the respiratory system
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Chlorhexidine, solution for external use 0.05% per 100 ml; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Ammonia, solution for external use, 10%, 100 ml each; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Amiodarone, solution for injections, 50 mg/ml, 3 ml each; Bisoprolol tablets 10 mg each; Bisoprolol tablets of 2.5 mg; Bisoprolol tablets of 5 mg; Water for injections ampoules of 5 ml; Activated charcoal tablets/capsules of 250 mg each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Captopril, tablets, 25 mg each; Carvedidol 12.5 mg tablets; Caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; Loperamide 2 mg tablets/capsules; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Meropenem, powder for injection/infusion, 1 g each; Nitroglycerin, sublingual tablets, 0.5 mg each; Prednisone, solution for injection, 30 mg/ml, 1 ml each; Salbutamol, inhalation under pressure, 100 μg/dose, 200 doses; Human insulin (short-acting), solution for injection, 100 U/ml, bottle, 10 ml; Fluconazole, solution for infusions, 2 mg/ml, 100 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Propofol, emulsion, 10 mg/ml, 50 ml each Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Type of packaging: Vial; Meropenem, powder for injection/infusion, 1 g Name Classifier and its corresponding code Quantity/Measurement units Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Type of packaging: Vial; Meropenem, powder for injections/infusions, 1 g Name Classifier and its corresponding code Quantity/Units of ...
Documents
Tender Notice